Literature DB >> 1332359

Clinical and pathophysiological aspects of neurological complications in renal failure.

P P De Deyn1, V K Saxena, H Abts, F Borggreve, R D'Hooge, B Marescau, R Crols.   

Abstract

A review of the neurological complications presenting in uremia and an account of their presumed pathophysiology is given. With the introduction of different dialytic procedures during the last twenty years, the incidence and severity of neurological complications have declined. Nevertheless, some disturbances related to the uremic syndrome fail to respond to dialytic therapy and these therapeutic measures may even be responsible for the appearance of some new abnormalities. The clinical manifestations of uremic encephalopathy and polyneuropathy are presented. The review of the presumed pathophysiology of these syndromes illustrates the still existing controversies. Nevertheless, some promising new lines of research are reviewed. In addition, some complications of uremic treatment, including dialysis disequilibrium syndrome and dialysis encephalopathy are presented.

Entities:  

Mesh:

Year:  1992        PMID: 1332359

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.396


  12 in total

1.  Cerebrocellular swelling in the presence of uraemic guanidino compounds: ameliorative effects of taurine.

Authors:  R O Law
Journal:  Neurochem Res       Date:  2005-12       Impact factor: 3.996

2.  Behavioural deficits during the acute phase of mild renal failure in mice.

Authors:  M Al Banchaabouchi; R D'Hooge; B Marescau; P P De Deyn
Journal:  Metab Brain Dis       Date:  1999-09       Impact factor: 3.584

3.  Differential associations between systemic markers of disease and white matter tissue health in middle-aged and older adults.

Authors:  Chang-Woo Ryu; Jean-Philippe Coutu; Anna Greka; H Diana Rosas; Geon-Ho Jahng; Bruce R Rosen; David H Salat
Journal:  J Cereb Blood Flow Metab       Date:  2016-07-21       Impact factor: 6.200

4.  Acute kidney injury leads to inflammation and functional changes in the brain.

Authors:  Manchang Liu; Yideng Liang; Srinivasulu Chigurupati; Justin D Lathia; Mikhail Pletnikov; Zhaoli Sun; Michael Crow; Christopher A Ross; Mark P Mattson; Hamid Rabb
Journal:  J Am Soc Nephrol       Date:  2008-04-02       Impact factor: 10.121

5.  Aberrant functional connectome in neurologically asymptomatic patients with end-stage renal disease.

Authors:  Xiaofen Ma; Guihua Jiang; Shumei Li; Jinhui Wang; Wenfeng Zhan; Shaoqing Zeng; Junzhang Tian; Yikai Xu
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

6.  Aberrant cortical thickness in neurologically asymptomatic patients with end-stage renal disease.

Authors:  Jianwei Dong; Xiaofen Ma; Wuhong Lin; Mengchen Liu; Shishun Fu; Lihua Yang; Guihua Jiang
Journal:  Neuropsychiatr Dis Treat       Date:  2018-08-02       Impact factor: 2.570

7.  Regional homogeneity changes in hemodialysis patients with end stage renal disease: in vivo resting-state functional MRI study.

Authors:  Cheng Li; Huan-Huan Su; Ying-Wei Qiu; Xiao-Fei Lv; Sheng Shen; Wen-Feng Zhan; Jun-Zhang Tian; Gui-Hua Jiang
Journal:  PLoS One       Date:  2014-02-06       Impact factor: 3.240

8.  Spatial Disassociation of Disrupted Functional Connectivity for the Default Mode Network in Patients with End-Stage Renal Disease.

Authors:  Xiaofen Ma; Junzhang Tian; Zhanhong Wu; Xiaopeng Zong; Jianwei Dong; Wenfeng Zhan; Yikai Xu; Zibo Li; Guihua Jiang
Journal:  PLoS One       Date:  2016-08-25       Impact factor: 3.240

9.  Synaptic plasticity in hippocampal CA1 neurons and learning behavior in acute kidney injury, and estradiol replacement in ovariectomized rats.

Authors:  Fatemeh Sharifi; Parham Reisi; Maryam Malek
Journal:  BMC Neurosci       Date:  2019-10-04       Impact factor: 3.288

10.  Abnormal rich club organization in end-stage renal disease patients before dialysis initiation and undergoing maintenance hemodialysis.

Authors:  Shaohui Ma; Ming Zhang; Yang Liu; Dun Ding; Peng Li; Xueying Ma; Hongjuan Liu; Junya Mu
Journal:  BMC Nephrol       Date:  2020-11-26       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.